# Mission Pharmacal Company – FDA Inspection, Apr 4, 2019

Source: https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/9828023a-ad18-41ad-b502-0f962d22608b
Source feed: FDA_Inspections

> FDA inspection 1085124 of Mission Pharmacal Company, April 04, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085124
- Company Name: Mission Pharmacal Company
- Inspection Date: 2019-04-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1219105 - 2023-06-27
- [FDA Inspection 1180935 - 2022-09-22](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/8319387b-93ab-42e5-9d7e-44089969d14c)
- [FDA Inspection 1067651 - 2018-09-20](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/558027af-5b62-496d-a991-0175c5a4846e)
- [FDA Inspection 1019109 - 2017-05-04](https://www.keypedia.com/records/fda_inspections/mission-pharmacal-company/c221bfd4-0ff6-4b79-b9cb-04276bae4388)
- FDA Inspection 866629 - 2014-02-07

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anitha-p-govada/07f94777-660b-4b81-b63c-54f3b4a8635e)
- [FDA Associated Person](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)

Company: https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9